Annual Operating Profit
-$22.00 M
-$32.37 M-312.24%
31 December 2023
Summary:
Pharming Group NV annual operaing income is currently -$22.00 million, with the most recent change of -$32.37 million (-312.24%) on 31 December 2023. During the last 3 years, it has fallen by -$98.26 million (-128.85%). PHAR annual operating profit is now -128.85% below its all-time high of $76.26 million, reached on 31 December 2020.PHAR Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$4.11 M
+$7.23 M+231.62%
30 September 2024
Summary:
Pharming Group NV quarterly operating income is currently $4.11 million, with the most recent change of +$7.23 million (+231.62%) on 30 September 2024. Over the past year, it has increased by +$2.20 million (+115.30%). PHAR quarterly operating profit is now -82.67% below its all-time high of $23.71 million, reached on 30 September 2020.PHAR Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$31.16 M
+$2.20 M+6.60%
30 September 2024
Summary:
Pharming Group NV TTM operating income is currently -$31.16 million, with the most recent change of +$2.20 million (+6.60%) on 30 September 2024. Over the past year, it has dropped by -$6.15 million (-24.60%). PHAR TTM operating profit is now -138.19% below its all-time high of $81.59 million, reached on 30 September 2020.PHAR TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PHAR Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -312.2% | +115.3% | -24.6% |
| 3 y3 years | -128.8% | +326.0% | -198.8% |
| 5 y5 years | -150.6% | -78.0% | -157.6% |
PHAR Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -128.8% | at low | -77.0% | +122.2% | -197.1% | +6.6% |
| 5 y | 5 years | -128.8% | at low | -82.7% | +122.2% | -138.2% | +6.6% |
| alltime | all time | -128.8% | +44.5% | -82.7% | +122.2% | -138.2% | +19.7% |
Pharming Group NV Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.11 M(-231.6%) | -$31.16 M(-6.6%) |
| June 2024 | - | -$3.12 M(-80.9%) | -$33.36 M(+33.8%) |
| Mar 2024 | - | -$16.31 M(+3.0%) | -$24.94 M(+11.9%) |
| Dec 2023 | -$22.00 M(-312.2%) | -$15.83 M(-929.8%) | -$22.29 M(-10.9%) |
| Sept 2023 | - | $1.91 M(-64.0%) | -$25.01 M(+30.6%) |
| June 2023 | - | $5.30 M(-138.8%) | -$19.15 M(+188.9%) |
| Mar 2023 | - | -$13.66 M(-26.3%) | -$6.63 M(-167.2%) |
| Dec 2022 | $10.37 M(-45.5%) | -$18.55 M(-338.9%) | $9.86 M(-69.3%) |
| Sept 2022 | - | $7.76 M(-56.4%) | $32.08 M(+42.6%) |
| June 2022 | - | $17.82 M(+530.8%) | $22.50 M(+44.7%) |
| Mar 2022 | - | $2.83 M(-23.1%) | $15.55 M(-18.2%) |
| Dec 2021 | $19.01 M(-75.1%) | $3.67 M(-302.1%) | $19.01 M(-39.7%) |
| Sept 2021 | - | -$1.82 M(-116.7%) | $31.54 M(-44.7%) |
| June 2021 | - | $10.87 M(+73.0%) | $57.07 M(-6.6%) |
| Mar 2021 | - | $6.28 M(-61.2%) | $61.09 M(-19.9%) |
| Dec 2020 | $76.26 M(+11.7%) | $16.21 M(-31.6%) | $76.26 M(-6.5%) |
| Sept 2020 | - | $23.71 M(+59.2%) | $81.59 M(+6.5%) |
| June 2020 | - | $14.89 M(-30.6%) | $76.58 M(+0.8%) |
| Mar 2020 | - | $21.45 M(-0.5%) | $75.94 M(+11.3%) |
| Dec 2019 | $68.25 M(+57.0%) | $21.55 M(+15.3%) | $68.25 M(+26.1%) |
| Sept 2019 | - | $18.69 M(+31.1%) | $54.12 M(+2.8%) |
| June 2019 | - | $14.26 M(+3.7%) | $52.63 M(+11.8%) |
| Mar 2019 | - | $13.75 M(+85.3%) | $47.09 M(+8.4%) |
| Dec 2018 | $43.46 M(+65.3%) | $7.42 M(-56.9%) | $43.46 M(-8.3%) |
| Sept 2018 | - | $17.20 M(+97.3%) | $47.39 M(+17.6%) |
| June 2018 | - | $8.72 M(-13.8%) | $40.28 M(+24.8%) |
| Mar 2018 | - | $10.12 M(-10.8%) | $32.27 M(+22.7%) |
| Dec 2017 | $26.29 M(-316.6%) | $11.35 M(+12.4%) | $26.29 M(+97.1%) |
| Sept 2017 | - | $10.10 M(+1333.3%) | $13.34 M(-3558.4%) |
| June 2017 | - | $704.60 K(-83.0%) | -$385.60 K(-91.2%) |
| Mar 2017 | - | $4.14 M(-357.7%) | -$4.41 M(-63.7%) |
| Dec 2016 | -$12.14 M | -$1.61 M(-55.7%) | -$12.14 M(-15.5%) |
| Sept 2016 | - | -$3.62 M(+9.2%) | -$14.36 M(+1.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2016 | - | -$3.32 M(-7.7%) | -$14.14 M(-1.3%) |
| Mar 2016 | - | -$3.59 M(-6.1%) | -$14.33 M(+2.1%) |
| Dec 2015 | -$14.03 M(-501.1%) | -$3.82 M(+12.2%) | -$14.03 M(-352.7%) |
| Sept 2015 | - | -$3.41 M(-2.7%) | $5.55 M(+35.7%) |
| June 2015 | - | -$3.50 M(+6.1%) | $4.09 M(-7.1%) |
| Mar 2015 | - | -$3.30 M(-120.9%) | $4.40 M(+25.9%) |
| Dec 2014 | $3.50 M(-136.7%) | $15.76 M(-423.6%) | $3.50 M(-120.8%) |
| Sept 2014 | - | -$4.87 M(+52.8%) | -$16.84 M(+10.9%) |
| June 2014 | - | -$3.19 M(-24.2%) | -$15.18 M(+41.9%) |
| Mar 2014 | - | -$4.20 M(-8.1%) | -$10.70 M(+12.1%) |
| Dec 2013 | -$9.54 M(-55.5%) | -$4.58 M(+42.6%) | -$9.54 M(+142.2%) |
| Sept 2013 | - | -$3.21 M(-347.8%) | -$3.94 M(-48.8%) |
| June 2013 | - | $1.30 M(-142.4%) | -$7.70 M(-58.0%) |
| Mar 2013 | - | -$3.05 M(-397.5%) | -$18.34 M(-14.4%) |
| Dec 2012 | -$21.43 M(-10.5%) | $1.03 M(-114.7%) | -$21.43 M(-20.9%) |
| Sept 2012 | - | -$6.97 M(-25.4%) | -$27.08 M(+1.4%) |
| June 2012 | - | -$9.34 M(+52.1%) | -$26.70 M(+11.2%) |
| Mar 2012 | - | -$6.14 M(+32.8%) | -$24.01 M(+0.3%) |
| Dec 2011 | -$23.93 M(-14.9%) | -$4.63 M(-29.8%) | -$23.93 M(-14.4%) |
| Sept 2011 | - | -$6.59 M(-1.0%) | -$27.95 M(+2.0%) |
| June 2011 | - | -$6.65 M(+9.7%) | -$27.41 M(+4.2%) |
| Mar 2011 | - | -$6.06 M(-29.9%) | -$26.31 M(-2.3%) |
| Dec 2010 | -$28.14 M(-29.1%) | -$8.65 M(+43.0%) | -$26.93 M(-1.0%) |
| Sept 2010 | - | -$6.04 M(+8.7%) | -$27.19 M(-12.1%) |
| June 2010 | - | -$5.56 M(-16.8%) | -$30.93 M(-16.2%) |
| Mar 2010 | - | -$6.68 M(-24.9%) | -$36.90 M(-4.9%) |
| Dec 2009 | -$39.66 M(+12.7%) | -$8.90 M(-9.0%) | -$38.78 M(+29.8%) |
| Sept 2009 | - | -$9.78 M(-15.1%) | -$29.88 M(+48.7%) |
| June 2009 | - | -$11.53 M(+34.6%) | -$20.09 M(+134.6%) |
| Mar 2009 | - | -$8.57 M | -$8.57 M |
| Dec 2008 | -$35.20 M(-0.7%) | - | - |
| Dec 2007 | -$35.46 M(+52.0%) | - | - |
| Dec 2006 | -$23.33 M(+6.8%) | - | - |
| Dec 2005 | -$21.84 M | - | - |
FAQ
- What is Pharming Group NV annual operaing income?
- What is the all time high annual operating profit for Pharming Group NV?
- What is Pharming Group NV annual operating profit year-on-year change?
- What is Pharming Group NV quarterly operating income?
- What is the all time high quarterly operating profit for Pharming Group NV?
- What is Pharming Group NV quarterly operating profit year-on-year change?
- What is Pharming Group NV TTM operating income?
- What is the all time high TTM operating profit for Pharming Group NV?
- What is Pharming Group NV TTM operating profit year-on-year change?
What is Pharming Group NV annual operaing income?
The current annual operating profit of PHAR is -$22.00 M
What is the all time high annual operating profit for Pharming Group NV?
Pharming Group NV all-time high annual operaing income is $76.26 M
What is Pharming Group NV annual operating profit year-on-year change?
Over the past year, PHAR annual operaing income has changed by -$32.37 M (-312.24%)
What is Pharming Group NV quarterly operating income?
The current quarterly operating profit of PHAR is $4.11 M
What is the all time high quarterly operating profit for Pharming Group NV?
Pharming Group NV all-time high quarterly operating income is $23.71 M
What is Pharming Group NV quarterly operating profit year-on-year change?
Over the past year, PHAR quarterly operating income has changed by +$2.20 M (+115.30%)
What is Pharming Group NV TTM operating income?
The current TTM operating profit of PHAR is -$31.16 M
What is the all time high TTM operating profit for Pharming Group NV?
Pharming Group NV all-time high TTM operating income is $81.59 M
What is Pharming Group NV TTM operating profit year-on-year change?
Over the past year, PHAR TTM operating income has changed by -$6.15 M (-24.60%)